Phoslactomycin targets cysteine-269 of the protein phosphatase 2A catalytic subunit in cells

Takayuki Teruya, Siro Simizu, Naoki Kanoh, Hiroyuki Osada

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

According to the chemical genetic approach, small molecules that bind directly to proteins are used to analyze protein function, thereby enabling the elucidation of complex mechanisms in mammal cells. Thus, it is very important to identify the molecular targets of compounds that induce a unique phenotype in a target cell. Phoslactomycin A (PLMA) is known to be a potent inhibitor of protein Ser/Thr phosphatase 2A (PP2A); however, the inhibitory mechanism of PP2A by PLMA has not yet been elucidated. Here, we demonstrated that PLMA directly binds to the PP2A catalytic subunit (PP2Ac) in cells by using biotinylated PLMA, and the PLMA-binding site was identified as the Cys-269 residue of PP2Ac. Moreover, we revealed that the Cys-269 contributes to the potent inhibition of PP2Ac activity by PLMA. These results suggest that PLMA is a PP2A-selective inhibitor and is therefore expected to be useful for future investigation of PP2A function in cells.

Original languageEnglish
Pages (from-to)2463-2468
Number of pages6
JournalFEBS Letters
Volume579
Issue number11
DOIs
Publication statusPublished - 2005 Apr 25
Externally publishedYes

Fingerprint

Protein Phosphatase 2
Cysteine
Catalytic Domain
Phosphoric Monoester Hydrolases
Proteins
Mammals
phoslactomycin A
Binding Sites
Phenotype
Molecules

Keywords

  • Chemical genetics
  • Phoslactomycin
  • Phosphatase
  • Protein serine/threonine phosphatase 2A

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Phoslactomycin targets cysteine-269 of the protein phosphatase 2A catalytic subunit in cells. / Teruya, Takayuki; Simizu, Siro; Kanoh, Naoki; Osada, Hiroyuki.

In: FEBS Letters, Vol. 579, No. 11, 25.04.2005, p. 2463-2468.

Research output: Contribution to journalArticle

Teruya, Takayuki ; Simizu, Siro ; Kanoh, Naoki ; Osada, Hiroyuki. / Phoslactomycin targets cysteine-269 of the protein phosphatase 2A catalytic subunit in cells. In: FEBS Letters. 2005 ; Vol. 579, No. 11. pp. 2463-2468.
@article{cb7604018e0946e8814bfa2c36c8f0bf,
title = "Phoslactomycin targets cysteine-269 of the protein phosphatase 2A catalytic subunit in cells",
abstract = "According to the chemical genetic approach, small molecules that bind directly to proteins are used to analyze protein function, thereby enabling the elucidation of complex mechanisms in mammal cells. Thus, it is very important to identify the molecular targets of compounds that induce a unique phenotype in a target cell. Phoslactomycin A (PLMA) is known to be a potent inhibitor of protein Ser/Thr phosphatase 2A (PP2A); however, the inhibitory mechanism of PP2A by PLMA has not yet been elucidated. Here, we demonstrated that PLMA directly binds to the PP2A catalytic subunit (PP2Ac) in cells by using biotinylated PLMA, and the PLMA-binding site was identified as the Cys-269 residue of PP2Ac. Moreover, we revealed that the Cys-269 contributes to the potent inhibition of PP2Ac activity by PLMA. These results suggest that PLMA is a PP2A-selective inhibitor and is therefore expected to be useful for future investigation of PP2A function in cells.",
keywords = "Chemical genetics, Phoslactomycin, Phosphatase, Protein serine/threonine phosphatase 2A",
author = "Takayuki Teruya and Siro Simizu and Naoki Kanoh and Hiroyuki Osada",
year = "2005",
month = "4",
day = "25",
doi = "10.1016/j.febslet.2005.03.049",
language = "English",
volume = "579",
pages = "2463--2468",
journal = "FEBS Letters",
issn = "0014-5793",
publisher = "Elsevier",
number = "11",

}

TY - JOUR

T1 - Phoslactomycin targets cysteine-269 of the protein phosphatase 2A catalytic subunit in cells

AU - Teruya, Takayuki

AU - Simizu, Siro

AU - Kanoh, Naoki

AU - Osada, Hiroyuki

PY - 2005/4/25

Y1 - 2005/4/25

N2 - According to the chemical genetic approach, small molecules that bind directly to proteins are used to analyze protein function, thereby enabling the elucidation of complex mechanisms in mammal cells. Thus, it is very important to identify the molecular targets of compounds that induce a unique phenotype in a target cell. Phoslactomycin A (PLMA) is known to be a potent inhibitor of protein Ser/Thr phosphatase 2A (PP2A); however, the inhibitory mechanism of PP2A by PLMA has not yet been elucidated. Here, we demonstrated that PLMA directly binds to the PP2A catalytic subunit (PP2Ac) in cells by using biotinylated PLMA, and the PLMA-binding site was identified as the Cys-269 residue of PP2Ac. Moreover, we revealed that the Cys-269 contributes to the potent inhibition of PP2Ac activity by PLMA. These results suggest that PLMA is a PP2A-selective inhibitor and is therefore expected to be useful for future investigation of PP2A function in cells.

AB - According to the chemical genetic approach, small molecules that bind directly to proteins are used to analyze protein function, thereby enabling the elucidation of complex mechanisms in mammal cells. Thus, it is very important to identify the molecular targets of compounds that induce a unique phenotype in a target cell. Phoslactomycin A (PLMA) is known to be a potent inhibitor of protein Ser/Thr phosphatase 2A (PP2A); however, the inhibitory mechanism of PP2A by PLMA has not yet been elucidated. Here, we demonstrated that PLMA directly binds to the PP2A catalytic subunit (PP2Ac) in cells by using biotinylated PLMA, and the PLMA-binding site was identified as the Cys-269 residue of PP2Ac. Moreover, we revealed that the Cys-269 contributes to the potent inhibition of PP2Ac activity by PLMA. These results suggest that PLMA is a PP2A-selective inhibitor and is therefore expected to be useful for future investigation of PP2A function in cells.

KW - Chemical genetics

KW - Phoslactomycin

KW - Phosphatase

KW - Protein serine/threonine phosphatase 2A

UR - http://www.scopus.com/inward/record.url?scp=17644377575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17644377575&partnerID=8YFLogxK

U2 - 10.1016/j.febslet.2005.03.049

DO - 10.1016/j.febslet.2005.03.049

M3 - Article

VL - 579

SP - 2463

EP - 2468

JO - FEBS Letters

JF - FEBS Letters

SN - 0014-5793

IS - 11

ER -